Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Use this AMGN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AMGN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AMGN SEC filings page. Lician reads the product cache first so this HTML stays unique to Amgen Inc even when a live quote feed is slow.
Latest cached year on this hub. Full AMGN income, balance, and cash tables.